Vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy
Huang, Y.-r.
Zhonghua Nan Ke Xue 11(1): 76-79
2005
ISSN/ISBN: 1009-3591 PMID: 15704689 Document Number: 592705
More than one-third of men may experience erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy. A recent study has shown that vardenafil, a phosphodiesterase 5 inhibitor, could significantly improve the key indices of erectile function in men after unilateral or bilateral nerve-sparing radical retropubic prostatectomy. Few adverse events were observed in the study.